Abstract
Objective
The purpose of this review is to propose a critical role for vascular endothelial growth factor (VEGF) in mediating the transfer of amniotic fluid from the amniotic compartment through the fetal membranes and fetal surface of the placenta into fetal blood.
Methods
Experimental findings in humans and animal models on the action of VEGF in mediating fluid transfer are reviewed and interpreted in order to postulate a proposed mechanism for VEGF regulation of amniotic fluid absorption through the fetal membranes and placenta.
Results
Recent scientific advances suggest that up-regulation of VEGF gene expression in the amnion and chorion is associated with increased transfer of amniotic fluid into fetal blood. The possible mechanisms of action for VEGF appear to involve regulation of intramembranous blood vessel proliferation and membrane transport via passive permeation as well as nonpassive transcytotic vesicular movement of fluid.
Conclusion
Currently evolving concepts suggest that amniotic fluid volume is regulated through modulation of the rate of intramembranous absorption of amniotic fluid by both passive and nonpassive mechanisms. The permeability factor VEGF appears to be a critical regulator of amniotic fluid transport in the fetal membranes.
Similar content being viewed by others
References
Konduri GG, Fewell JE. Oligohydramnios. In: Brace RA, Ross MG, Robilliard JE, eds. Fetal and neonatal body fluids: The scientific basis for clinical practice. Perinatology Press, 1989:157–74.
Healy DL. Polyhydramnios: An alternative hypothesis. In: Brace RA, Ross MG, Robilliard JE, eds. Fetal and neonatal body fluids: The scientific basis for clinical practice. Perinatology Press, 1989:175–85.
Brace RA. Progress toward understanding the regulation of amniotic fluid volume: Water and solute fluxes in and through the fetal extraplacental membranes. Placenta 1995;16:1–18.
Gilbert WM, Brace RA. The missing link in amniotic fluid volume regulation: Intramembranous absorption. Obstet Gynecol 1989;74:748–54.
Ross MG, Brace RA. Amniotic fluid biology—basic and clinical aspects. J Matern Fetal Med 2001;10:2–109.
Gilbert WM, Brace RA. Novel determination of filtration coefficient of ovine placenta and intramembranous pathway. Am J Physiol 1990;259:R1281–8.
Jang PR, Brace RA. Amniotic fluid composition changes during urine drainage and tracheoesophageal occlusion in fetal sheep. Am J Obstet Gynecol 1992;167:1732–41.
Matsumoto LC, Cheung CY, Brace RA. Effect of esophageal ligation on amniotic fluid volume and urinary flow rate in fetal sheep. Am J Obstet Gynecol 2000;182:699–705.
Faber JJ, Anderson DF. Regulatory response of intramembranous absorption of amniotic fluid to infusion of exogenous fluid in sheep. Am J Physiol 1999;277:R236–42.
Matsumoto LC, Cheung CY, Brace RA. Prolonged hypoxia increases urinary flow without the development of polyhydramnios in the ovine fetus. Am J Obstet Gynecol 2001;184:1008–14.
Daneshmand SS, Cheung CY, Brace RA. Regulation of amniotic fluid volume by intramembranous absorption in sheep: Role of passive permeability and vascular endothelial growth factor. Am J Obstet Gynecol 2003;188:786–93.
Abramovich DR, Page KR. Pathways of water exchange in the fetoplacental unit at mid-pregnancy. J Obstet Gynecol Br Commonw 1972;79:1099–102.
Gitlin D, Kumate J, Morales C, Noriega L, Arevalo N. The turnover of amniotic fluid protein in the human conceptus. Am J Obset Gynecol 1972;113:632–45.
Heller L. Intrauterine amino acid feeding of the fetus. In: Bode H, Warshaw J, eds. Parenternal nutrition in infancy and childhood. Plenum Press, 1974:206–13.
Schrder HJ, Dehne K, Andreas TH, Rago S, Rybakowshki CH. Diffusive transfer of water and glucose across the chorionic plate of the isolated human term placenta. Placenta 1999;20:59–63.
Reynolds WA, Pitkin RM, Hodaria AA. Transfer of iodide into amniotic fluid by the normal and the nephrectomized subhuman primate fetus. Am J Obstet Gynecol 1969;104:633–41.
Gilbert WM, Eby-Wilkens E, Tarantal AF. The missing link in rhesus monkey amniotic fluid volume regulation: Intramembranous absorption. Obstet Gynecol 1997;89:462–5.
Brace RA, Gilbert WM, Thornburg KL. Vascularization of the ovine amnion and chorion: A morphometric characterization of the surface area of the intramembranous pathway. Am J Obstet Gynecol 1992;161:1747–55.
Gilbert WM, Cheung CY, Brace RA. Rapid intramembranous absorption into the fetal circulation of arginine vasopressin injected intraamniotically. Am J Obstet Gynecol 1991;164:1013–20.
Kullama LK, Agnew CL, Day L, Ervin MT, Ross MG. Ovine fetal swallowing and renal responses to oligohydramnios. Am J Physiol 1994;266:R972–8.
Ross MG, Sherman DJ, Schreyer P, Ervin MG, Day L, Humme J. Fetal rehydration via intraamniotic fluid: Contribution of fetal swallowing. Pediatr Res 1991;29:214–7.
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306–9.
Conolly DT. Vascular permeability factor: A unique regulator of blood vessel function. J Cell Biochem 1991;47:219–23.
Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. J Cancer Res 1986;46:5629–32.
Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579–86.
DeVries C, Escobedo JA, Ueno H, Houck K, Ferrera N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989–91.
Ferrara N, Davis-Symth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4–25.
Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD, Smith SK. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993;99:609–15.
Jackson MR, Carney EW, Lye SJ, Ritchie JW. Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 1994;15:341–53.
Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K. Immunochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996;17:111–21.
Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995;12:235–43.
Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Pleven R, Ferrara N, Smith SK. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 1994;51:524–30.
Cooper JC, Sharkey AM, McLaren J, Charnock-Jones DS, Smith SK. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry. J Reprod Fertil 1995;105:205–13.
Clark DE, Smith SK, Sharley AM, Charnock-Jones DS. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 1996;11:1090–8.
Vuckovic M, Ponting J, Terman BI, Niketic V, Seif MW, Kuman S. Expression of the vascular endothelial growth factor receptor KDR, in human placenta. J Anat 1996;188:361–6.
Bogic LV, Brace RA, Cheung CY. Cellular localization of vascular endothelial growth factor in ovine placenta and fetal membranes. Placenta 2000;21:203–9.
Barleon B, Hauser S, Schollman C, et al. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem 1994;54:56–66.
Winther H, Ahmed A, Dantzer V. Immunochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, flt-1 and KDR, in the porcine placenta and non-pregnant uterus. Placenta 1999;20:35–43.
Cheung CY, Brace RA. Developmental expression of vascular endothelial growth factor and its receptors in ovine placenta and fetal membranes. J Soc Gynecol Investig 1999;6:179–85.
Bogic LV, Brace RA, Cheung CY. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes. Placenta 2001;22:265–75.
Cheung CY, Brace RA. Ovine vascular endothelial growth factor: Nucleotide sequence and expression in fetal tissues. Growth Factors 1998;16:11–22.
Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991;91:1806–14.
Charnock-Jones DS, Sharkey AM, Rajput-Williams J, et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993;48:1120–8.
Anthony FW, Wheeler T, Elcock CL, Pickett M, Thomas EJ. Short report: Identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 1994;15:557–61.
Cheung CY, Singh M, Ebaugh MJ, Brace RA. Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 1995;173:753–9.
Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18–32.
Matsumoto LC, Bogic LV, Brace RA, Cheung CY. Fetal esophageal ligation induces VEGF expression in fetal membranes. Am J Obstet Gynecol 2001;184:175–84.
Vintzileos AM, Fleming AD, Scorza WE, et al. Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 1991;165:707–13.
Cock ML, McCrabb GJ, Wlodek ME, Harding R. Effects of prolonged hypoxemia on fetal renal function and amniotic fluid volume in sheep. Am J Obstet Gynecol 1997;176:320–6.
Wlodek ME, Brace RA, Cock ML, Hooper SB, Harding R. Endocrine responses of fetal sheep to prolonged hypoxemia with and without acidemia: Relation to urine production. Am J Physiol 1995;268:F868–75.
Brace RA, Wlodek ME, McCrabb GJ, Harding R. Swallowing and urine flow responses of the ovine fetus to 24 hours of hypoxia. Am J Physiol 1994;266:R1345–52.
Sherman DJ, Ross MG, Day L, Humme J, Ervin MG. Fetal swallowing: Response to graded maternal hypoxemia. J Appl Physiol 1991;71:1856–61.
Matsumoto LC, Bogie LV, Brace RA, Cheung CY. Prolonged hypoxia up-regulates vascular endothelial growth factor messenger RNA expression in ovine fetal membranes and placenta. Am J Obstet Gynecol 2002;186:303–10.
Brace RA. Fetal blood volume, urine flow, swallowing and amniotic fluid volume responses to long-term intravascular saline infusions. Am J Obstet Gynecol 1989;161:1049–54.
Walker DW, Mitchell MD. Prostaglandins in urine of foetal lambs. Nature 1978;271:161–2.
Kelly EJ, Newell SJ, Brownlee KG, et al. Role of epidermal growth factor and transforming growth factor alpha in the developing stomach. Arch Dis Child Fetal Neonatal Ed 1997;76:F158–62.
Varner MW, Dildy GA, Hunter C, Dudley DJ, Clark SL, Mitchell MD. Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies. J Soc Gynecol Investig 1996;3:17–9.
Koizumi N, Inatomi T, Sotozono C, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Current Eye Res 2000;20:173–7.
Kudolo GB, DeFronzo RA. Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. Prostaglandins Other Lipid Mediators 1999;57:87–98.
Fagerudd JA, Groop PH, Honkanen E, Teppo AM, Greonhagen-Riska C. Urinary excretion of TGF-beta 1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int 1997;63:S195–7.
Szabo A, Lutz J, Schleimer K, et al. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int 2000;57:982–91.
Sawdy RJ, Slater DM, Dennes WJ, Sullivan MH, Bennett PR. The roles of the cyclooxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta 2000;21:54–7.
Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83–7.
Höper MM, Voelkel NF, Bates TO, et al. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol 1997;17:748–56.
Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993;4:121–33.
Gille J, Swerlick RA, Caughman SW. Transforming growth factor-α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 1997;16:750–9.
Pertovaara L, Kaipainen A, Mustonen T, et al. Vascular endothelial growth factor is induced in responses to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271–4.
Ahmed A, Dearn S, Shams M, et al. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAK. FASEB J 1998;12:831–43.
Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is down-regulated by corticosteroids. Am J Respir Cell Mol Biol 1997;16:398–406.
Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649–52.
Williams B, Quinn-Baker A, Gallagher B. Serum and plateletderived growth factor-induced expression of vascular permeability factor mRNA by human vascular smooth muscle cells in vitro. Clin Sci 1995;88:141–7.
Perkins DJ, Kniss DA. Rapid and transient induction of cyclooxygenase 2 by epidermal growth factor in human amnionderived WISH cells. Biochem J 1997;321:677–81.
Casey ML, Korte K, MacDonald PC. Epidermal growth factor stimulation of prostaglandin E2 biosynthesis in amnion cells. J Biol Chem 1988;263:7846–54.
Smith SK, Kelly RW. Effect of platelet-activating factor on the release of PGF2α and PGE2 by separated cells of human endometrium. J Reprod Fertil 1988;82:271–6.
Alvi SA, Brown NL, Bennett PR, Elder MG, Sullivan MH. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol Hum Reprod 1999;5:476–80.
Ershov AV, Bazan NG. Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors. J Neurosci Res 1999;58:254–61.
Ladoux A, Freiin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993;195:1005–10.
Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843–8.
Minchenko A, Bauer T, Salceda A, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994;71:374–9.
Liu Y, Cox SR, Morita T, Kourembnas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995;77:638–43.
Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761–6.
Shima DT, Deutsch U, D’Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203–8.
Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996;271:2746–53.
Claffey KP, Shih SC, Mullen A, et al. Identification of human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 1998;9:469–81.
Ji YS, Xu Q, Schmedtje JF Jr. Hypoxia induces high-mobilitygroup protein I (Y) and transcription of the cyclooxygenasegene 2 in human vascular endothelium. Circ Res 1998;83:295–304.
Schmedtje JF Jr, YS Ji, Liu WL, Dubois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB transcription factor in human vascular endothelial cells. J Biol Chem 1997;272:601–8.
Chida M, Voelkel NF. Effects of acute and chronic hypoxia on rat lung cyclooxygenase. Am J Physiol 1996;270:L872–8.
Akiséu M, Keulteursay N, Coker I, Heuseyinov A. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate 1998;74:439–44.
Chen D, Chen W. Changes of distribution of platelet activating factor in the lung of rats with hypoxic pulmonary hypertension. Chin Med Sci J 1996;109:776–9.
Cai Y, Han M, Luo L, Song W, Zhou X. Increased expression of PDGF and c-myc genes in lungs and pulmonary arteries of pulmonary hypertensive rats induced by hypoxia. Chin Med Sci J 1996;11:152–6.
Berg JT, Breen EC, Fu Z, Matheu-Costello O, West JB. Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-36 in lung parenchyma. Am J Respir Crit Care Med 1998;158:1920–8.
Starvi GT, Hong Y, Zachary IC, et al. Hypoxia and platelet-derived growth factor-36 synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth ceUs. FEBS Lett 1995;358:311–5.
Faber JJ, Anderson DF. Absorption of amniotic fluid by amniochonon in sheep. Am J Physiol 2002;282:H850–4.
Parry-Jones E, Priya S. A study of the elasticity and tension of fetal membranes and of the relation of the area of the gestational sac to the area of the uterine cavity. Br J Obstet Gynaecol 1976;83:205–12.
Millar LK, Stollberg J, DeBuque L, Bryant-Greenwood G. Fetal membrane distention: Determination of the intrauterine surface area and distention of the fetal membranes preterm and at term. Am J Obstet Gynecol 2000;182:128–34.
Breier G. Angiogenesis in embryonic development—a review. Placenta 2000;14:S11–5.
Ong S, Lash G, Baker PN. Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Clin Obstet Gynaecol 2000;14:969–80.
Le V, McLaughlin J, Brace RA, Cheung CY. Vascular endothelial growth factor induced proliferation of ovine umbilical vein endothelial cells. J Soc Gynecol Investig 1998;5(Suppl):158A.
Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265:H586–92.
Yang HT, Yan Z, Abraham JA, Terjung RL. VEGF121- and 36 FGF- induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol 2001;280:H1097–104.
Banbury J, Siemionow M, Porvasnik S, Petras S, Browne E. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000;106:1541–6.
Cherng JM, Lin CM, Lin CL, et al. Effects of VEGF121 and/or VEGF165 gene transfection on collateral circulation development. J Formos Med Assoc 2000;99:603–11.
Hedriana HL, Brace RA, Gilbert WM. Changes in blood flow to the ovine chorion and amnion across gestation. J Soc Gynecol Investig 1995;2:727–34.
Lingwood BE, Wintour EM. Permeability of ovine amnion and amniochorion on urea and water. Obstet Gynecol 1983;61:227–32.
Wintour EM, Lingwood BE, Towstoless MK. Passive permeability of ovine amnion and allantois to chloride—gestational changes. Placenta 1988;9:599–606.
Michel CC. Capillaries, caveolae, calcium and cyclic nucleotides: A new look at microvascular permeability. J Mol Cell Cardiol 1998;30:2541–6.
Palade GE, Bruns RR. Structural modulations of plasmalemma vesicles. J Cell Biol 1968;37:633–49.
Rothberg KG, Heuser JE, Donzeil WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992;68:673–82.
Michel CC, Curry FE. Microvascular permeability. Physiol Rev 1999;79:703–61.
Bautzmann H, Schmidt W, Lemburg P. Experimental electron-and light-microscopical studies on the function of the amnion— apparatus of the chick, the cat and man. Anat Anz 1960;108:305–11.
Armstrong WD, Wilt JC, Pritchard ET. Vacuolation in the human amnion cell studied by time-lapse photography and electron microscopy. Am J Obstet Gynecol 1968;102:932–48.
King BF. Cell surface specializations and intercellular junctions in human amniotic epithelium: An electron microscopic and freeze-fracture study. Anat Rec 1982;203:73–8.
Shandley L, Alcorn D, Wintour EM. Ovine amniotic and allantoic epithelia across gestation. Anat Rec 1997;248:542–53.
Lyden TW, Anderson CL, Robinson JM. The endothelium but not the syncytiotrophoblast of human placenta expresses caveolae. Placenta 2002;23:640–52.
Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267:26031–7.
Bates DO, Curry FE. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol 1996;271:H2520–8.
Fujii E, Irie K, Ohba KI, et al. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn-Shmiedebergs Arch Pharmacol 1997;356:475–80.
Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 1999;6:23–44.
Kohn S, Nagy J, Dvorak H, Dvorak A. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992;67:596–607.
Vasile E, Hong Q, Dvorak HF, Dvorak AM. Caveolae and vesiculo/vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating matrigel/collagen gels. J Histochem Cytochem 1999;47:159–67.
Chen J, Braet F, Brodsky S, et al. VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells. Am J Physiol 2002;282:C1053–63.
Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial genestrations in vitro. J Cell Biol 1998;140:947–59.
Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, Caldwell RB. VEGF-induced permeability increase is mediated by caveolae. Invest Ophthalmol Vis Sci 1999;40:157–67.
Liu J, Razani B, Tang S, Terman BI, Ware JA, Lisanti MP. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. J Biol Chem 1999;274:15781–5.
Carmeliet P, Ferreira V, Briere G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435–9.
Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439–42.
Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995;376:62–6.
Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66–70.
Wang D, Donner DB, Warren RS. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF. J Biol Chem 2000;275:15905–11.
Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrar N, Zioncheck TF. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 1998;273:29979–85.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by Public Health Service Awards HD 33054 and HD 35890 from the National Institute of Child Health and Human Development.
Rights and permissions
About this article
Cite this article
Cheung, C.Y. Vascular Endothelial Growth Factor Activation of Intramembranous Absorption: A Critical Pathway for Amniotic Fluid Volume Regulation. Reprod. Sci. 11, 63–74 (2004). https://doi.org/10.1016/j.jsgi.2003.09.002
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jsgi.2003.09.002